Safeguard Radioligand Therapy System SRTS

  • Safeguard Radioligand Therapy System SRTS 1
  • Safeguard Radioligand Therapy System SRTS 2
Product Description

The SRTS is a device for transport, administration, and waste management of radioactive substances. This device is designed to enable the safe handling and administration of radiotherapeutic agents by providing effective shielding against ionizing radiation.With the expected increased use of Radioligand Therapies this device supports capacity building for implementation of RLT in clinical practice (upscaling)

Read more Show less

ONCOFUSE MED

  • Country/Region:
    Austria
  • On CPHI since:
    2025
  • Employees:
    1 - 24
Company types
Drug delivery device Supplier/Manufacturer
Start-up
View company profile
Categories
more categories Show less
Specifications
  • Details
    At Oncofuse, we are committed to transforming radioligand therapy into a safe, scalable, and accessible cancer treatment. By developing end-to-end solutions that reduce radiation exposure, and simplify wastemanagement, we enable healthcare providers to deliver cutting-edgeoncological care beyond hospitals and highly specialized centers, bringing hope and healing closer to patients worldwide.

More specifications Fewer specifications

ONCOFUSE MED

  • Country/Region:
    Austria
  • On CPHI since:
    2025
  • Employees:
    1 - 24
Company types
Drug delivery device Supplier/Manufacturer
Start-up
View company profile

More Products from ONCOFUSE MED (1)

  • Safeguard Radioligand Therapy System

    Product Safeguard Radioligand Therapy System

    The Safeguard Radioligand Therapy System is an integrated, end-to-end medical device solution designed to make radioligand therapy scalable, safe, and sustainable across the full care pathway—from transport and administration to waste management. Built to address the operational and safety challenges that...